Allos Raises $5M to Apply Causal AI Across Complex Drug Reformulation
— Novel use of Causal AI revives long-stalled development pathways across complex generics and next-generation medicines for chronic disease — Allos bends the cost-risk curve of drug development and formulation for complex generics, making specialty medicines easier to take, optimized for long-term use, and economically viable — Allos’ approach gives drug developers, innovators, and generic […]